Gene therapy and small molecules are opening the door to new curative approaches, but access continues to be a barrier for ...

Joy, curiosity, creativity, beauty, passion, and connection.’ These doctors embrace optimistic side gigs as a powerful ...

Patients with primary and secondary empty sella show distinct clinical and endocrine trajectories over a median follow-up of ...

Drinking artificially sweetened beverages was not associated with an increased risk for liver cancer, but consumption of ...

A meta-analysis shows that the lateral placental position is independently linked to increased odds of preterm birth, small ...

Formal food challenges before oral immunotherapy allowed early delabelling of peanut allergy in more than one third of ...

In contrast to concerns of lean mass loss with GLP-1 receptor agonists, a large population-based study found lower fracture rates with semaglutide than with other weight-loss medications.

Experts call for more women’s Heart Centers across Europe, citing persistent disparities in cardiovascular diagnosis, ...

Many health insurance companies don’t even cover GLP-1s for physicians. Yoni Freedhoff, MD, asks why the lack of coverage.

Finerenone treatment is associated with a reduced risk for sudden death among adults with chronic kidney disease, type 2 diabetes, or heart failure, study finds.

Traditionally trained clinicians in dermatology can overcome their discomfort with alternative and complementary therapies ...

In adults aged 75 years or older, the risk for death from causes other than colorectal cancer greatly exceeded the 10-year risk for diagnosis or colorectal cancer-specific death.